The Requirements Checklist to Get Ibrance (Palbociclib) Covered by UnitedHealthcare in Ohio: Appeals, Forms & Timelines
Answer Box: Fast Track to Ibrance Coverage
UnitedHealthcare requires prior authorization for Ibrance (palbociclib) in HR+/HER2- metastatic breast cancer with documented trial of two CDK4/6 inhibitors first. Submit PA via UHC Provider Portal with pathology confirming HR+/HER2- status, staging evidence, and treatment plan combining Ibrance with an